This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2mp9
From Proteopedia
(Difference between revisions)
| (6 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Solution structure of an potent antifungal peptide Cm-p5 derived from C. muricatus== | |
| + | <StructureSection load='2mp9' size='340' side='right'caption='[[2mp9]]' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[2mp9]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Cenchritis_muricatus Cenchritis muricatus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2MP9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2MP9 FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2mp9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2mp9 OCA], [https://pdbe.org/2mp9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2mp9 RCSB], [https://www.ebi.ac.uk/pdbsum/2mp9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2mp9 ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/AFP_CENMR AFP_CENMR] | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Antimicrobial peptides form part of the first line of defense against pathogens for many organisms. Current treatments for fungal infections are limited by drug toxicity and pathogen resistance. Cm-p5 (SRSELIVHQRLF), a peptide derived from the marine mollusk Cenchritis muricatus peptide Cm-p1, has a significantly increased fungistatic activity against pathogenic Candida albicans (minimal inhibitory concentration, 10 microg/ml; EC50, 1.146 microg/ml) while exhibiting low toxic effects against a cultured mammalian cell line. Cm-p5 as characterized by circular dichroism and nuclear magnetic resonance revealed an alpha-helical structure in membrane-mimetic conditions and a tendency to random coil folding in aqueous solutions. Additional studies modeling Cm-p5 binding to a phosphatidylserine bilayer in silico and isothermal titration calorimetry using lipid monophases demonstrated that Cm-p5 has a high affinity for the phospholipids of fungal membranes (phosphatidylserine and phosphatidylethanolamine), only moderate interactions with a mammalian membrane phospholipid, low interaction with ergosterol, and no interaction with chitin. Adhesion of Cm-p5 to living C. albicans cells was confirmed by fluorescence microscopy with FITC-labeled peptide. In a systemic candidiasis model in mice, intraperitoneal administration of Cm-p5 was unable to control the fungal kidney burden, although its low amphiphaticity could be modified to generate new derivatives with improved fungicidal activity and stability.-Lopez-Abarrategui, C., McBeth, C., Mandal, S. M., Sun, Z. J., Heffron, G., Alba-Menendez, A., Migliolo, L., Reyes-Acosta, O., Garcia-Villarino, M., Nolasco, D. O., Falcao, R., Cherobim, M. D., Dias, S. C., Brandt, W., Wessjohann, L., Starnbach, M., Franco, O. L., Otero-Gonzalez, A. J. Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae). | ||
| - | + | Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae).,Lopez-Abarrategui C, McBeth C, Mandal SM, Sun ZJ, Heffron G, Alba-Menendez A, Migliolo L, Reyes-Acosta O, Garcia-Villarino M, Nolasco DO, Falcao R, Cherobim MD, Dias SC, Brandt W, Wessjohann L, Starnbach M, Franco OL, Otero-Gonzalez AJ FASEB J. 2015 Aug;29(8):3315-25. doi: 10.1096/fj.14-269860. Epub 2015 Apr 28. PMID:25921828<ref>PMID:25921828</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| + | </div> | ||
| + | <div class="pdbe-citations 2mp9" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Cenchritis muricatus]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Heffron G]] | ||
| + | [[Category: Mcbeth C]] | ||
| + | [[Category: Otero-Gonzales AJ]] | ||
| + | [[Category: Starnbach MN]] | ||
| + | [[Category: Sun ZJ]] | ||
| + | [[Category: Wagner G]] | ||
Current revision
Solution structure of an potent antifungal peptide Cm-p5 derived from C. muricatus
| |||||||||||
